维普期刊资源整合服务平台（V6.5）

44篇 您的检索式：作者名="CAMPI I"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study显示文摘	SALVI M VANNUCCHI G CAMPI I	2007	Eur J Endocrinol2007，156，1：	1
2	Analysis of eddy current distributions in the CMS magnet yoke during the solenoid discharge显示文摘	KLYUKHIN V I CAMPI D CUR(E) B	2005	Nuclear Science2005，52，3：	1
3	Ef?caey of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression显示文摘	Salvi M Vannucchi G Campi I	2006	EurJ Endocrinol2006，154，：	1
4	Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab : an open study显示文摘	Salvi M Vannucchi G Campi I el al	2007	Eur J Endocrinol2007，156，：	1
5	New innnunomodulators in the treatment of Grave's ophthalmopathy显示文摘	Salvi M Vannucchi G Campi I	2008	Ann endocrinol(Paris)2008，69，2：	1
6	Treatment of Graves, disease and associated ophthalmopathy wiyh the anti-CD20 monoelonal antibody rittLximab: an open study显示文摘	Salvi M Vannucchi G Campi I	2007	Eur J Endocrinol2007，156，1：	1
7	Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression 显示文摘	Salvi M Vannucchi G Campi I	2006	Eur J Endocrinol2006，154，：	1
8	Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosupp ression1显示文摘	SALVI M VANNUCCHI G CAMPI I	2006	Eur J Endocrinol2006，154，4：	1
9	Treatment of Graves'disease and associated ophthalmopathywith the anti-CD20 monoclonal antibody rituximab:an open study显示文摘	SALVI M VANNUCCHI G CAMPI I	2007	Eur J Endocrinol2007，156，1：	1
10	New immunomodulators in the treatment of Graves'ophthalmopathy显示文摘	SALVI M VANNUCCHI G CAMPI I	2008	Ann Endocrinol (Paris)2008，69，2：	1
11	Appiication of a new classification to a breast cancer registry: demographic, clinical, and prognostic features of incident cases, Palermo Province, 2002-2004显示文摘	Zarcone M Amodio R Campi I	2009	Ann N YAcad Sci2009，1155，：	1
12	Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal anti- body rituximab : an open study 显示文摘	Salvi M Vannucchi G Campi I	2007	Eur J Endocrinol2007，156，1：	1
13	Rituximab in the treatment of thyroid eye disease:science fiction?显示文摘	SALVI M VANNUCCHI G CAMPI I	2009	Orbit2009，28，4：	1
14	Rituximab treatment in Patients with active Graves' orbitopathy:effects on proinflammatory and humoral immune reactions显示文摘	Vannucchi G CamPi I Bonomi M		0，，：	1
15	Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis显示文摘	Vannucchi G Campi I Covelli D	2009	J Clin Endocrinol Metab2009，94，9：	1
16	Rituximab treatment in patients with active Graves' orbitopathy:effects on proinflammatory andhumoral immune reactions显示文摘	Vannucchi G Campi I Bonomi M		0，，：	1
17	Efficacy of rituximab treatment for thyroid-associated oph- thalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression 显示文摘	Salvi M Vaimucchi G Campi I Rossi S Bonara P Sbrozzi F	2006	Eur J Endocrinol2006，15，4：	1
18	Treatment of Graves' disease and associated ophthalmopa- thy with the anti-CD20 monoclonal antibody rituximab :an open study显示文摘	Salvi M Vannucchi G Campi I Curro N Dazzi D Simonetta S	2007	Eur J Endocrinol2007，156，1：	1
19	Graves' orbitopathy activation after radioactive Iodine therapy with and without steroid prophylaxis显示文摘	Vannucchi G Campi I Covelli D	2009	J Clin Endocrinol Metab2009，94，9：	1
20	Treatment of Graves disease and associated ophthalmopathy with the anti CD20 monoclonal anti- body rituximab: an open study显示文摘	Salvi M Vannucchi G Campi I	2007	Eur J Endoerinol2007，156，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示